within Pharmacolibrary.Drugs.ATC.D;

model D04AB06
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00013333333333333334,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D04AB06</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tetracaine is an ester-type local anesthetic used primarily for topical anesthesia of the eye, nose, and throat, and occasionally for spinal anesthesia. It acts as a sodium channel blocker, preventing nerve impulse conduction. It is approved and still used clinically, especially as a topical and spinal anesthetic.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters based on general properties of ester-type local anesthetics. No specific published human PK studies found for tetracaine.</p><h4>References</h4><ol><li><p>Terndrup, TE, et al., &amp; Karatay, CM (1991). Plasma cocaine and tetracaine levels following application of topical anesthesia in a swine laceration model. <i>The American journal of emergency medicine</i> 9(6) 539–543. DOI:<a href=\"https://doi.org/10.1016/0735-6757(91)90107-u\">10.1016/0735-6757(91)90107-u</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1930392/\">https://pubmed.ncbi.nlm.nih.gov/1930392</a></p></li><li><p>Davies, LB, et al., &amp; Birchall, JC (2017). Accelerating Topical Anaesthesia Using Microneedles. <i>Skin pharmacology and physiology</i> 30(6) 277–283. DOI:<a href=\"https://doi.org/10.1159/000479530\">10.1159/000479530</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28881348/\">https://pubmed.ncbi.nlm.nih.gov/28881348</a></p></li><li><p>Fang, C, et al., &amp; Chen, HZ (2008). Synergistically enhanced transdermal permeation and topical analgesia of tetracaine gel containing menthol and ethanol in experimental and clinical studies. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 68(3) 735–740. DOI:<a href=\"https://doi.org/10.1016/j.ejpb.2007.02.007\">10.1016/j.ejpb.2007.02.007</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17398083/\">https://pubmed.ncbi.nlm.nih.gov/17398083</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D04AB06;
